These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 27253664)
21. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484 [TBL] [Abstract][Full Text] [Related]
22. Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study. Schöfl C; Honegger J; Droste M; Grussendorf M; Finke R; Plöckinger U; Berg C; Willenberg HS; Lammert A; Klingmüller D; Jaursch-Hancke C; Tönjes A; Schneidewind S; Flitsch J; Bullmann C; Dimopoulou C; Stalla G; Mayr B; Hoeppner W; Schopohl J J Clin Endocrinol Metab; 2014 Dec; 99(12):E2789-93. PubMed ID: 25093619 [TBL] [Abstract][Full Text] [Related]
23. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature]. Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897 [TBL] [Abstract][Full Text] [Related]
24. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion. Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469 [TBL] [Abstract][Full Text] [Related]
25. Risk category system to identify pituitary adenoma patients with Caimari F; Hernández-Ramírez LC; Dang MN; Gabrovska P; Iacovazzo D; Stals K; Ellard S; Korbonits M; J Med Genet; 2018 Apr; 55(4):254-260. PubMed ID: 29440248 [TBL] [Abstract][Full Text] [Related]
27. The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas. Lloyd C; Grossman A Endocrine; 2014 Aug; 46(3):387-96. PubMed ID: 24366639 [TBL] [Abstract][Full Text] [Related]
28. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort. Preda V; Korbonits M; Cudlip S; Karavitaki N; Grossman AB Eur J Endocrinol; 2014 Nov; 171(5):659-66. PubMed ID: 25184284 [TBL] [Abstract][Full Text] [Related]
29. Germline AIP variants in sporadic young acromegaly and pituitary gigantism: clinical and genetic insights from a Han Chinese cohort. Xiang B; Zhang X; Liu W; Mao B; Zhao Y; Wang Y; Gong W; Ye H; Li Y; Zhang Z; Yu Y; He M Endocrine; 2024 Sep; 85(3):1346-1356. PubMed ID: 38851643 [TBL] [Abstract][Full Text] [Related]
30. Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition. Morgan RM; Hernández-Ramírez LC; Trivellin G; Zhou L; Roe SM; Korbonits M; Prodromou C PLoS One; 2012; 7(12):e53339. PubMed ID: 23300914 [TBL] [Abstract][Full Text] [Related]
31. AIP and its interacting partners. Trivellin G; Korbonits M J Endocrinol; 2011 Aug; 210(2):137-55. PubMed ID: 21454441 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466 [TBL] [Abstract][Full Text] [Related]
33. A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family. Iwata T; Yamada S; Ito J; Inoshita N; Mizusawa N; Ono S; Yoshimoto K Endocr Pathol; 2014 Sep; 25(3):273-81. PubMed ID: 24789813 [TBL] [Abstract][Full Text] [Related]
34. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance. Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736 [TBL] [Abstract][Full Text] [Related]